Patents by Inventor Aws Nashef

Aws Nashef has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7156868
    Abstract: A catheter having a heat transfer device at or near its distal end, wherein the heat transfer device is layered or coated onto or into the catheter wall is described. The heat transfer device is preferably a flexible film having one or more electrical resistor flow paths thereon or therethrough, or is disposed directly onto the catheter wall by a deposition process. The heat transfer device may alternatively be formed by a length of the catheter wall being formed wholly, substantially of partly from doped material able to act as a heat transfer device upon application of power therethrough. The heat transfer device is preferably powered by one or more metal wires co-extruded within the catheter body.
    Type: Grant
    Filed: August 25, 2000
    Date of Patent: January 2, 2007
    Assignee: Omega Critical Care Limited
    Inventors: Aws Nashef, Ted Vander Wiede, Robert Macnair, Stephen Wilson, Simon Andrews
  • Patent number: 5997573
    Abstract: Dilation restrictor apparatus for use in conjunction with prosthetic vascular grafts, including venous valve grafts made from preserved bioprosthetic venous valves. The dilation restrictors limit the extent to which a blood vessel may dilate adjacent to a point whereat a cut end of the blood vessel has been anastomosed to an implant graft. Also disclosed is a related method of anastomosing the prosthetic graft to an existing vein segment of a patient.
    Type: Grant
    Filed: July 29, 1997
    Date of Patent: December 7, 1999
    Assignee: Baxter International, Inc.
    Inventors: Rodolfo C. Quijano, Aws Nashef
  • Patent number: 5824061
    Abstract: Exovascular and endovascular stent devices and associated support/restrictor assemblies for use in conjunction with prosthetic vascular grafts, including venous valve grafts made from preserved bioprosthetic venous valves. Also disclosed are methods for preparing vascular grafts such as venous valve grafts using the devices and assemblies of the present invention.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: October 20, 1998
    Assignee: Baxter International Inc.
    Inventors: Rodolfo C. Quijano, Aws Nashef
  • Patent number: 5609626
    Abstract: Exovascular and endovascular stent devices and associated support/restrictor assemblies for use in conjunction with prosthetic vascular grafts, including venous valve grafts made from preserved bioprosthetic venous valves. Also disclosed are methods for preparing vascular grafts such as venous valve grafts using the devices and assemblies of the present invention.
    Type: Grant
    Filed: June 22, 1994
    Date of Patent: March 11, 1997
    Assignee: Baxter International Inc.
    Inventors: R. C. Quijano, Aws Nashef
  • Patent number: 5500014
    Abstract: A biological valvular prosthesis defined by a chemically fixed biological derived conduit having at least one integrally formed tissue valve. The chemical fixation of the valve ensures that the leaflets remain open under normal forward blood flow conditions, but close under minimal backflow pressure. The biological valvular prostheses are useful in the replacement of venous valves and other biological valves. The biological valvular prosthesis may also be in the form of a tubular conduit bearing one tissue valve. This valvular conduit prosthesis is useful for the reconstruction of the pulmonary artery to correct various types of congenital defects.
    Type: Grant
    Filed: May 9, 1994
    Date of Patent: March 19, 1996
    Assignee: Baxter International Inc.
    Inventors: R. C. Quijano, Aws Nashef, Keith Myers
  • Patent number: 5327774
    Abstract: A method and device for testing artificial or natural venous valves. The device comprises chamber (10) a sample for mounting a test valve (V) on a liquid flow path and a muscle pump component (16) and/or respiratory pump component (50) and/or capacitance reservoir (58) and/or vertical hydrostatic column component (102) fluidly connected to the flow path to mimic the muscle pump, respiratory pump, capacitance and hydrostatic impedance effects on venous circulation in the mammalian body. Included in the invention are methods of testing venous valves by mimicking known hemodynamic flow conditions within a mammalian body.
    Type: Grant
    Filed: October 8, 1993
    Date of Patent: July 12, 1994
    Assignee: Baxter International Inc.
    Inventors: Than Nguyen, Aws Nashef, Amir H. Abolfathi, David W. Wieting, Denis Lee
  • Patent number: 5272909
    Abstract: A method and device for testing artificial or natural venous valves. The device comprises (a) a fixture for mounting a sample valve on a liquid flow path, (b) a muscle pump component and/or (o) respiratory pump component and/or (d) capacitance reservoir component and/or (e) vertical hydrostatic column component, all of the components being fluidly connected to the flow path to mimic the muscle pump, respiratory pump, capacitance and hydrostatic impedance effects of actual in situ venous circulation in the mammalian body. The invention includes methods of testing venous valves by mimicking known hemodynamic flow conditions within a mammalian body.
    Type: Grant
    Filed: April 25, 1991
    Date of Patent: December 28, 1993
    Assignee: Baxter International Inc.
    Inventors: Than Nguyen, Aws Nashef, Amir H. Abolfathi, David W. Wieting, Denis Lee
  • Patent number: 5002566
    Abstract: Calcification resistant bioprosthetic implants are made from tanned biological materials, such as porcine heart valves, bovine pericardium, human dura mater or the like, which has been impregnated with a calcification-mitigating effective amount of a ferric and/or stannic salt. The impregnated biological materials and processes are particularly advantageous for the preparation of bioprosthetic heart valves. These implants have been found to be highly resistant to calcification in vivo.
    Type: Grant
    Filed: April 18, 1989
    Date of Patent: March 26, 1991
    Assignee: Baxter International Inc.
    Inventors: Alain Carpentier, Sophie Carpentier, Aws Nashef
  • Patent number: 4597766
    Abstract: A tendon or ligament bioprosthesis comprised of a naturally occurring tendon or ligament isolated from an animal source, tanned with a bifunctional reagent capable of cross-linking biological tissue, at least one end of the tendon or ligament having attached thereto an intact decalcified chip of the bone from which the tendon or ligament was isolated. The presence of the decalcified bone chip provides a substrate which is receptive to the ingrowth of bone tissue when the bioprosthesis is implanted in a resected bone.
    Type: Grant
    Filed: October 26, 1984
    Date of Patent: July 1, 1986
    Assignee: American Hospital Supply Corporation
    Inventors: Said S. Hilal, Aws Nashef